Soleno Therapeutics(SLNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLNO Soleno Therapeutics

Pre-Mkt 04-29 04:22:23 EDT

73.64

+0.38

+0.52%

盘前74.19

+0.55+0.75%

04:11 EDT

High74.25	Low71.24	Vol904.44K
Open72.75	D1 Closing73.26	Amplitude4.11%
Mkt Cap3.68B	Tradable Cap2.60B	Total Shares49.91M
T/O66.16M	T/O Rate2.56%	Tradable Shares35.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SLNO","market":"US","secType":"STK","nameCN":"Soleno Therapeutics","latestPrice":73.64,"timestamp":1745870400000,"preClose":73.26,"halted":0,"volume":904436,"hourTrading":{"tag":"盘前","latestPrice":74.19,"preClose":73.64,"latestTime":"04:11 EDT","volume":102,"amount":7568.409792,"timestamp":1745914312919},"delay":0,"floatShares":35370900,"shares":49908300,"eps":-4.376999,"marketStatus":"Pre-Mkt","change":0.38,"latestTime":"04-29 04:22:23 EDT","open":72.75,"high":74.2542,"low":71.24,"amount":66159538.62179999,"amplitude":0.041144,"askPrice":81.39,"askSize":100,"bidPrice":64.93,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.376999,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":73.64,"preHourTrading":{"tag":"盘前","latestPrice":74.19,"preClose":73.64,"latestTime":"04:11 EDT","volume":102,"amount":7568.409792,"timestamp":1745914312919},"postHourTrading":{"tag":"盘后","latestPrice":73.36,"preClose":73.64,"latestTime":"19:41 EDT","volume":184464,"amount":13583882.34,"timestamp":1745883695445},"volumeRatio":0.9576983963108266,"impliedVol":0.5814,"impliedVolPercentile":0.1084},"requestUrl":"/m/hq/s/SLNO","defaultTab":"news","newsList":[{"id":"2529932253","title":"Soleno Therapeutics Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2529932253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529932253?lang=en_us&edition=full_marsco","pubTime":"2025-04-24 22:29","pubTimestamp":1745504940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLNO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 24, 2025 10:29 ET (14:29 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO"],"gpt_icon":0},{"id":"2529988713","title":"Soleno Therapeutics price target raised to $145 from $93 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2529988713","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529988713?lang=en_us&edition=full_marsco","pubTime":"2025-04-24 19:34","pubTimestamp":1745494494,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi raised the firm’s price target on Soleno Therapeutics (SLNO) to $145 from $93 and keeps an Overweight rating o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-price-target-raised-to-145-from-93-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-price-target-raised-to-145-from-93-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLNO"],"gpt_icon":0},{"id":"2529602934","title":"Piper Sandler Sticks to Its Buy Rating for Soleno Therapeutics (SLNO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529602934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529602934?lang=en_us&edition=full_marsco","pubTime":"2025-04-24 18:58","pubTimestamp":1745492302,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report), with a price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-soleno-therapeutics-slno?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-soleno-therapeutics-slno?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLNO"],"gpt_icon":0},{"id":"2529750792","title":"Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2529750792","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529750792?lang=en_us&edition=full_marsco","pubTime":"2025-04-23 19:00","pubTimestamp":1745406000,"startTime":"0","endTime":"0","summary":"The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, www.soleno.life.INDICATIONVYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome .Risk of Fluid OverloadEdema, including severe reactions associated with fluid overload, has been reported. Monitor for signs or symptoms of edema or fluid overload. VYKAT XR has not been studied in patients with compromised cardiac reserve and should be used with caution in these patients.Adverse ReactionsThe most common adverse reactions  included hypertrichosis, edema, hyperglycemia, and rash.Please see the fullPrescribing Information, including Medication Guide.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/soleno-therapeutics-report-first-quarter-110000138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PWS","BK4581","BK4590","HST","SLNO","BK4181","BK4218","BK4144","ET","BK4561","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2527491305","title":"Soleno Therapeutics Price Target Maintained With a $100.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2527491305","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527491305?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 19:13","pubTimestamp":1744715580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLNO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 15, 2025 07:13 ET (11:13 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO"],"gpt_icon":0},{"id":"2527015304","title":"Soleno Therapeutics announces VYKAT XR launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2527015304","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527015304?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 19:11","pubTimestamp":1744629081,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics (SLNO) announced the U.S. commercial availability of VYKAT XR extended-release tablets, the company’s treatment for hyperphagia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-announces-vykat-xr-launch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-announces-vykat-xr-launch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLNO","BK4139"],"gpt_icon":0},{"id":"2527985158","title":"Soleno: Prescriptions of Vykat Xr Have NOW Been Delivered to First Individuals Living With Prader-Willi Syndrome Who Have Been Prescribed Medication","url":"https://stock-news.laohu8.com/highlight/detail?id=2527985158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527985158?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 19:00","pubTimestamp":1744628455,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ025:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLNO","BK4139"],"gpt_icon":0},{"id":"2527538461","title":"Soleno Therapeutics Announces VYKAT(TM) XR Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2527538461","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527538461?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"First prescriptions delivered to individuals with PWSREDWOOD CITY, Calif., April  14, 2025  (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/14/3060770/0/en/Soleno-Therapeutics-Announces-VYKAT-TM-XR-Launch.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","03160","BK4585","BK4555","BK4588","PWS","TM","SLNO","BK4139","BK4604"],"gpt_icon":0},{"id":"2524192414","title":"High Growth Tech Stocks To Watch In The US April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524192414","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524192414?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:08","pubTimestamp":1743505684,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has dropped 3.4%, yet it remains up by 6.1% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and resilience amidst fluctuating market conditions.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 236 stocks from our US High Growth Tech and AI Stocks screener.Overview: Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics for treating rare diseases, with a market cap of $3.30 billion.NasdaqCM:SLNO Earnings and Revenue Growth as at Apr 2025. Overview: Verra Mobility Corporation provides smart mobility technology solutions and services across the United States, Australia, Europe, and Canada, with a market cap of $3.22 billion.Operations: The company genera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-110804833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0965509101.SGD","LU0965509010.AUD","BK4139","LU1244550494.USD","LU0456855351.SGD","LU0310800379.SGD","LU2089283258.USD","LU0170899867.USD","LU2129689605.HKD","LU1934455194.USD","LU1057294990.SGD","LU2087621335.USD","LU0738911758.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0708994859.HKD","SLNO","LU0985320562.USD","LU0661504455.SGD","LU1718418525.SGD","ABBV","SG9999015945.SGD","LU0320765646.SGD","VRRM","LU1244550577.SGD","LU1934455277.USD","LU0943347566.SGD","BK4533","BK4550","LU0211328371.USD","LU0417517546.SGD","LU1934455863.HKD","LU1496350171.SGD","LU2237443895.HKD","LU1003077747.HKD","LU0689472784.USD","LU2347655156.SGD","LU1551013425.SGD","IE00B2B36J28.USD","LU0820561909.HKD","LU1430594728.SGD","LU1551013342.USD","LU0949170772.SGD","LU1244550221.USD","LU1037948541.HKD","IE00BSNM7G36.USD","LU0795875169.SGD","LU2112291526.USD","LU1496350502.SGD","LU0310799852.SGD","IE00BVYPNW00.USD"],"gpt_icon":0},{"id":"2524181488","title":"Soleno Therapeutics Executives Cash In: Massive Stock Sales Unveiled!","url":"https://stock-news.laohu8.com/highlight/detail?id=2524181488","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524181488?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 10:01","pubTimestamp":1743472886,"startTime":"0","endTime":"0","summary":"New insider activity at Soleno Therapeutics ( ($SLNO) ) has taken place on April 1, 2025. In a series of significant transactions, key executives a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/soleno-therapeutics-executives-cash-in-massive-stock-sales-unveiled?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/soleno-therapeutics-executives-cash-in-massive-stock-sales-unveiled?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLNO"],"gpt_icon":0},{"id":"2523391038","title":"Soleno Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2523391038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523391038?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:15","pubTimestamp":1743419700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLNO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 07:15 ET (11:15 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO"],"gpt_icon":0},{"id":"2523119709","title":"Soleno Therapeutics price target raised to $100 from $70 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2523119709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523119709?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 18:15","pubTimestamp":1743416124,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Soleno Therapeutics (SLNO) to $100 from $70 and keeps a Buy rating on the shares after the FDA ap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-price-target-raised-to-100-from-70-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-price-target-raised-to-100-from-70-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLNO"],"gpt_icon":0},{"id":"2523642390","title":"Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523642390","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523642390?lang=en_us&edition=full_marsco","pubTime":"2025-03-30 10:39","pubTimestamp":1743302342,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look at where Soleno Therapeutics Inc.  stands against other stocks that outperformed broader market last week.Wall Street’s main indices traded lower week-on-week as investor sentiment continued to be dragged by the ongoing trade tensions globally.The tech-heavy Nasdaq was down by 2.59 percent versus its level on March 21. Meanwhile, the S&P 500 declined by 1.5 percent and the Dow Jones dropped by 0.956 percent.Ten individual stocks, on the other hand, managed to stay stronger, three of which were particularly notable as funds flocking to gold assets spilled over into their stocks.In this article, we listed last week’s 10 top performers and detailed the reasons behind their gains.Soleno Therapeutics soared by 46.6 percent week-on-week to end at $71.99 on Friday versus the $49.11 close on March 21, after securing the approval of the Food and Drug Administration  for it","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-soleno-therapeutics-inc-slno-023902199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SLNO","QLD","SQQQ","USAW.SI","BK4139","TSYW.SI",".IXIC","QID","NVIW.SI","NQmain","MNQmain","PSQ","USJW.SI","TQQQ"],"gpt_icon":1},{"id":"2523652812","title":"Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523652812","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523652812?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 10:30","pubTimestamp":1743215421,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a look at where Soleno Therapeutics Inc.  stands against other firms that end Friday strong.Wall Street’s main indices finished the trading week in the negative territory as investor sentiment was weighed down by economic uncertainties brought about by the ongoing trade tensions globally.The tech-heavy Nasdaq fell the heaviest, by 2.70 percent, followed by the S&P 500, by 1.97 percent, and the Dow Jones, by 1.69 percent.Despite the broader market downturn, 10 individual stocks showed a strong performance during the trading session, with three companies particularly notable for hitting new all-time highs.In this article, we listed Friday’s top performers and detailed the reasons behind their gains.Soleno Therapeutics jumped for a second day on Friday, adding another 6.83 percent to its valuation to end at $71.99 apiece after securing the approval of the Food and Drug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-soleno-therapeutics-inc-slno-023021837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","SQQQ","TQQQ","PSQ",".IXIC","TSYW.SI","USJW.SI","NQmain","SLNO","QID","MNQmain","BK4139","USAW.SI","QLD"],"gpt_icon":1},{"id":"2523654504","title":"Major Shareholder Sells Massive Stake in Soleno Therapeutics!","url":"https://stock-news.laohu8.com/highlight/detail?id=2523654504","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523654504?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 10:04","pubTimestamp":1743213862,"startTime":"0","endTime":"0","summary":"New insider activity at Soleno Therapeutics ( ($SLNO) ) has taken place on March 29, 2025. Significant shareholder Vivo Opportunity, LLC has divest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-shareholder-sells-massive-stake-in-soleno-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-shareholder-sells-massive-stake-in-soleno-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLNO","BK4139"],"gpt_icon":0},{"id":"2522506926","title":"Soleno Therapeutics Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2522506926","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522506926?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 22:40","pubTimestamp":1743172800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SLNO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 28, 2025 10:40 ET (14:40 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLNO"],"gpt_icon":0},{"id":"2522587296","title":"Soleno Therapeutics price target raised to $102 from $72 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2522587296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522587296?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 01:15","pubTimestamp":1743095730,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Soleno Therapeutics (SLNO) to $102 from $72 and keeps an Outperform rating on the shares. Published first o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-price-target-raised-to-102-from-72-at-baird-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soleno-therapeutics-price-target-raised-to-102-from-72-at-baird-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SLNO"],"gpt_icon":0},{"id":"2522840125","title":"Baird Raises Soleno Therapeutics' Price Target to $102 From $72, Outperform Rating Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2522840125","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522840125?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 01:08","pubTimestamp":1743095291,"startTime":"0","endTime":"0","summary":"Price: 70.08, Change: +21.11, Percent Change: +43.11","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLNO"],"gpt_icon":0},{"id":"2522589511","title":"Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522589511","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522589511?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 00:12","pubTimestamp":1743091973,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/03/44519152/gold-gains-1-td-synnex-shares-plunge-after-downbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","AUUD","DRMA","GTEC",".IXIC","QLD","SQQQ","NXU","BK4568","BK4161","BK4566","SLNO","TD","BK4023","BK4140","NQmain","PSQ","TQQQ","MNQmain","BK4007","BK4149","TSYW.SI","BK4585","QID","EQ","USAW.SI","SNX","NVIW.SI","BK4214","BK4207","BK4561","USJW.SI"],"gpt_icon":1},{"id":"2522589350","title":"Soleno Therapeutics Up Over 46%, On Track for Highest Close Since November 2016 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2522589350","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522589350?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 00:07","pubTimestamp":1743091620,"startTime":"0","endTime":"0","summary":"Soleno Therapeutics Inc  is currently at $71.86, up $22.89 or 46.73%. --Would be highest close since Nov. 25, 2016, when it closed at $72.75. --On pace for largest percent increase since Sept. 26, 2023, when it rose 504.97%. --Up 47.18% month-to-date; on pace for best month since Sept. 2023, when it rose 503.48%. --Down 89.05% from its all-time closing high of $656.25 on March 4, 2015. --Up 67.89% from 52 weeks ago , when it closed at $42.80. --Up 93.47% from its 52-week closing low of $37.14 on April 12, 2024. --Traded as high as $72.19; highest intraday level since March 15, 2019, when it hit $76.05. --Up 47.42% at today's intraday high; largest intraday percent increase since Sept. 26, 2023, when it rose as much as 583.97%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLNO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.soleno.life","stockEarnings":[{"period":"1week","weight":0.0683},{"period":"1month","weight":0.0229},{"period":"3month","weight":0.5035},{"period":"6month","weight":0.3216},{"period":"1year","weight":0.9435},{"period":"ytd","weight":0.6383}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.04369},{"month":2,"riseRate":0.272727,"avgChangeRate":0.254619},{"month":3,"riseRate":0.636364,"avgChangeRate":0.007758},{"month":4,"riseRate":0.454545,"avgChangeRate":0.048685},{"month":5,"riseRate":0.6,"avgChangeRate":0.083554},{"month":6,"riseRate":0.3,"avgChangeRate":-0.093001},{"month":7,"riseRate":0.3,"avgChangeRate":-0.060328},{"month":8,"riseRate":0.6,"avgChangeRate":0.005392},{"month":9,"riseRate":0.5,"avgChangeRate":0.450862},{"month":10,"riseRate":0.3,"avgChangeRate":-0.126436},{"month":11,"riseRate":0.5,"avgChangeRate":0.011011},{"month":12,"riseRate":0.363636,"avgChangeRate":0.064055}],"exchange":"NASDAQ","name":"Soleno Therapeutics","nameEN":"Soleno Therapeutics"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Soleno Therapeutics(SLNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Soleno Therapeutics(SLNO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Soleno Therapeutics,SLNO,Soleno Therapeutics股票,Soleno Therapeutics股票老虎,Soleno Therapeutics股票老虎国际,Soleno Therapeutics行情,Soleno Therapeutics股票行情,Soleno Therapeutics股价,Soleno Therapeutics股市,Soleno Therapeutics股票价格,Soleno Therapeutics股票交易,Soleno Therapeutics股票购买,Soleno Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Soleno Therapeutics(SLNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Soleno Therapeutics(SLNO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}